Bio-Techne Corporation (TECH) Bio-Techne’s Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories
Bio-Techne Corporation (NASDAQ: TECH) FY 2026 Other Release
19 articles, transcripts, and reports
Bio-Techne Corporation (NASDAQ: TECH) FY 2026 Other Release
Bio-Techne Corporation (NASDAQ: TECH) FY 2026 Corporate Conference
Bio-Techne Corporation (NASDAQ: TECH) Q2 2026 Earnings Call dated Feb. 04, 2026 Corporate Participants: David Clair — Vice President of...
Bio-Techne Corporation (NASDAQ: TECH) Q2 2026 Earnings Conference
Bio-Techne Corporation (NASDAQ: TECH) FY 2026 Other Release
Bio-Techne Corporation (NASDAQ: TECH) Sec Form 8K
Bio-Techne Corporation (NASDAQ: TECH) FY 2026 Management Update
Bio-Techne Corporation (NASDAQ: TECH) Q2 2025 Earnings Call dated Feb. 05, 2025 Corporate Participants: David Clair — Senior Director of Investor Relations Kim Kelderman —…
Bio-Techne Corporation (NASDAQ: TECH) Q3 2025 Earnings Call dated May. 07, 2025 Corporate Participants: David Clair — Vice President-Investor Relations Kim Kelderman — President &…
Bio-Techne Corporation (NASDAQ: TECH) Q4 2025 Earnings Call dated Aug. 06, 2025 Corporate Participants: David Clair — Vice President, Investor Relations and Corporate Development Kim…